Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women between the ages of 20 and 64 who have been diagnosed with advanced ovarian cancer
- People whose cancer has been classified as stage III or stage IV
- People whose overall health before surgery has been assessed by their doctor as falling within a moderate risk category (ASA classification II or III — confirm with trial site)
- People whose surgery is expected to last longer than 2 hours
Who may not be able to join:
- People with kidney problems (where a specific blood marker for kidney function is above a certain level) or significant liver problems
- People with a history of serious mental illness or mental health disorders, epilepsy, or vision impairment
- People who have had, or currently have, bleeding disorders, problems with blood clotting, or blood clot events in the past
- People who have blood clots in the veins of their lower legs or legs
- People who have taken blood-thinning or anti-bleeding medications in the month before surgery
- People who have a known allergy to tranexamic acid (TXA), a medication used to reduce bleeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 86+18758096745
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Elimination clearance rate (CL) of tranexamic acid; Interventricular clearance rate (Q) of tranexamic acid; Central ventricular volume (Vc) of tranexamic acid; peripheral ventricular volume (Vp) of tranexamic acid
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.